Dedicated to serving the biotech hub of Greater Boston, New England, and the Northeast corridor, our Shrewsbury facility offers flexible science, scale, and capacity at a convenient, close-by location. Our team balances scientific integrity, cost-effectiveness and regulatory compliance within the most stringent of time frames to deliver comprehensive support to meet critical deadlines which is particularly critical for novel method development and cell-based assays.
- GLP Toxicology
- Acute Toxicology
- PK/PD and DMPK
- In vivo Pharmacology
- General pharmacology
- Cardiovascular and metabolic disease
- Custom studies for rare and orphan diseases
- Necropsy and histopathology
- Clinical sample analysis
- Surgical models
- Pharmacokinetics – PK
- Formulations and analytical chemistry
- Immunology and biomarkers
- Immunoanalytical PK and ADA
- Anatomic and clinical pathology
- Clinical support services
We are invested in your projects and our team is truly committed to make your innovation a reality. From inception to prescription, we are here for you.
Frequently Asked Questions (FAQs) About our Shrewsbury Facility
What type of technology supports your laboratory sciences capabilities?
We work with a diverse set of tools and platforms such as LC-MS, flow cytometry, electrochemiluminescence bead-based multiplexing assays, Quanterix, and Bdna assays.
What type of modalities do you have experience with?
We work with a range of drug modalities including small molecules, cell and gene therapies, conjugated antibodies, oligonucleotides, peptides, vaccines and medical devices.
How many animal rooms are at the site and what types of species are available?
The facility has over 90 animal rooms which are used to conduct studies in rodents, dogs, rabbits and non-human primates. These range from acute toxicology and dose range findings studies to general toxicology studies in a comprehensive offering of administration routes.